Ultra-high-resolution 40 keV virtual monoenergetic imaging using spectral photon-counting CT in high-risk patients for coronary stenoses - Scorecard - MDSpire

Ultra-high-resolution 40 keV virtual monoenergetic imaging using spectral photon-counting CT in high-risk patients for coronary stenoses

  • By

  • Guillaume Fahrni

  • Sara Boccalini

  • Hugo Lacombe

  • Fabien de Oliveira

  • Angèle Houmeau

  • Florie Francart

  • Marjorie Villien

  • David C. Rotzinger

  • Antoine Robert

  • Philippe Douek

  • Salim A. Si-Mohamed

  • December 11, 2024

  • 0 min

Share

Clinical Scorecard: High-Resolution 40 keV Virtual Monoenergetic Imaging via Spectral Photon-Counting CT in Patients at Elevated Risk for Coronary Stenosis

At a Glance

CategoryDetail
ConditionCoronary artery disease (CAD) assessment in high-risk patients
Key MechanismsUse of spectral photon-counting CT (SPCCT) with photon-counting detectors (PCDs) enabling ultra-high-resolution virtual monoenergetic images (VMIs) at 40 keV and 70 keV
Target PopulationHigh-risk cardiovascular patients referred for coronary computed tomography angiography (CCTA)
Care SettingTertiary cardiothoracic university hospital imaging department

Key Highlights

  • SPCCT provides ultra-high-resolution imaging (up to 250 µm) with improved VMI quality compared to dual-energy CT (DECT).
  • 40 keV VMIs improve contrast enhancement and may reduce iodine contrast volume, addressing ecological and patient safety concerns.
  • SPCCT uses energy-resolving photon-counting detectors that reduce noise and allow spectral imaging with multiple energy bins.

Guideline-Based Recommendations

Diagnosis

  • Use coronary computed tomography angiography (CCTA) as a non-invasive test for CAD assessment in low to intermediate and high-risk patients.
  • Consider spectral photon-counting CT (SPCCT) for improved image quality and resolution in coronary stenosis evaluation.

Management

  • Administer iodinated contrast media adjusted by patient weight (65–75 mL Iomeprol 400 mg/mL) with saline flush during CCTA.
  • Use sublingual nitroglycerine and oral beta-blockers as needed to optimize heart rate for imaging.

Monitoring & Follow-up

  • Record and compare radiation dose indices (CTDIvol and DLP) between DECT and SPCCT systems.
  • Perform image quality assessment by experienced observers blinded to imaging modality.

Risks

  • Exclude patients with contraindications to iodinated contrast or renal failure (eGFR < 30 mL/min) to minimize risk of contrast-induced nephropathy.
  • Monitor for venous complications related to iodine contrast administration.

Patient & Prescribing Data

High-risk cardiovascular patients undergoing CCTA with both DECT and SPCCT within 3 days

SPCCT allows acquisition of ultra-high-resolution VMIs at 40 keV and 70 keV, potentially improving diagnostic accuracy and reducing iodine contrast volume compared to DECT.

Clinical Best Practices

  • Perform CCTA using retrospective ECG-gating helical acquisition with target heart rate of 60 bpm.
  • Use ultra-high-resolution reconstruction parameters (voxel size ~0.43 mm3) and iterative reconstruction algorithms tailored to each CT system.
  • Generate VMIs at both 40 keV and 70 keV to optimize contrast and reduce artifacts.
  • Ensure blinded, randomized qualitative image assessment by experienced cardiac imaging observers.

References

Original Source(s)

Related Content